Jim Simons
SVA

Jim Simons’s Sinovac Biotech, Ltd SVA Stock Holding History

Jim Simons’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
1,312,520
– – ﹤0.01% 3793
2025
Q4 		$0 Hold
1,312,520
– – ﹤0.01% 3917
2025
Q3 		$0 Hold
1,312,520
– – ﹤0.01% 4038
2025
Q2 		$849K Buy
+1,312,520
New +$849K ﹤0.01% 2589
2024
Q3 		– Sell
-1,312,520
Closed -$849K – 4023
2024
Q2 		$849K Hold
1,312,520
– – ﹤0.01% 2413
2024
Q1 		$849K Buy
+1,312,520
New +$849K ﹤0.01% 2579
2023
Q4 		– Sell
-2,375,841
Closed -$1.54M – 4316
2023
Q3 		$1.54M Hold
2,375,841
– – ﹤0.01% 2024
2023
Q2 		$1.54M Buy
+2,375,841
New +$1.54M ﹤0.01% 2172
2022
Q4 		– Sell
-2,375,841
Closed -$1.54M – 4599
2022
Q3 		$1.54M Hold
2,375,841
– – ﹤0.01% 2215
2022
Q2 		$1.54M Buy
+2,375,841
New +$1.54M ﹤0.01% 2385
2022
Q1 		– Sell
-2,375,841
Closed -$1.54M – 4683
2021
Q4 		$1.54M Hold
2,375,841
– – ﹤0.01% 2357
2021
Q3 		$1.54M Hold
2,375,841
– – ﹤0.01% 2291
2021
Q2 		$1.54M Hold
2,375,841
– – ﹤0.01% 2426
2021
Q1 		$1.54M Hold
2,375,841
– – ﹤0.01% 2394
2020
Q4 		$1.54M Hold
2,375,841
– – ﹤0.01% 2282
2020
Q3 		$1.54M Hold
2,375,841
– – ﹤0.01% 2277
2020
Q2 		$1.54M Hold
2,375,841
– – ﹤0.01% 2322
2020
Q1 		$1.54M Hold
2,375,841
– – ﹤0.01% 2196
2019
Q4 		$1.54M Hold
2,375,841
– – ﹤0.01% 2435
2019
Q3 		$15.4M Hold
2,375,841
– – 0.01% 1114
2019
Q2 		$15.4M Hold
2,375,841
– – 0.01% 1122
2019
Q1 		$15.4M Sell
2,375,841
-12,732
-0.5% -$83.7K 0.01% 1121
2018
Q4 		$16.6M Sell
2,388,573
-59,703
-2% -$436K 0.02% 1001
2018
Q3 		$18.7M Sell
2,448,276
-85,154
-3% -$615K 0.02% 979
2018
Q2 		$18.9M Sell
2,533,430
-106,070
-4% -$834K 0.02% 955
2018
Q1 		$22.7M Sell
2,639,500
-47,900
-2% -$395K 0.02% 862
2017
Q4 		$21.2M Buy
2,687,400
+517,200
+24% +$3.87M 0.02% 910
2017
Q3 		$15.3M Buy
2,170,200
+355,900
+20% +$2.43M 0.02% 1059
2017
Q2 		$12.2M Buy
1,814,300
+134,810
+8% +$739K 0.02% 1141
2017
Q1 		$9.62M Buy
1,679,490
+154,690
+10% +$896K 0.01% 1273
2016
Q4 		$9M Buy
1,524,800
+49,800
+3% +$300K 0.01% 1298
2016
Q3 		$8.7M Buy
1,475,000
+78,900
+6% +$464K 0.02% 1229
2016
Q2 		$8.28M Buy
1,396,100
+61,500
+5% +$377K 0.02% 1264
2016
Q1 		$8.53M Sell
1,334,600
-19,500
-1% -$117K 0.02% 1249
2015
Q4 		$7.75M Buy
1,354,100
+61,321
+5% +$330K 0.02% 1166
2015
Q3 		$6.57M Buy
1,292,779
+29,579
+2% +$157K 0.02% 1193
2015
Q2 		$6.63M Buy
1,263,200
+77,000
+6% +$407K 0.02% 1245
2015
Q1 		$5.88M Buy
1,186,200
+9,838
+0.8% +$48.5K 0.01% 1253
2014
Q4 		$6.15M Sell
1,176,362
-89,638
-7% -$457K 0.01% 1160
2014
Q3 		$6.09M Buy
1,266,000
+91,000
+8% +$489K 0.02% 1059
2014
Q2 		$6.63M Buy
1,175,000
+143,289
+14% +$870K 0.02% 1072
2014
Q1 		$7.43M Sell
1,031,711
-23,285
-2% -$154K 0.02% 1031
2013
Q4 		$6.46M Buy
1,054,996
+158,396
+18% +$954K 0.02% 1041
2013
Q3 		$5.36M Buy
896,600
+503,000
+128% +$2.4M 0.01% 1124
2013
Q2 		$1.55M Buy
+393,600
New +$1.46M ﹤0.01% 1723

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Jim Simons's SVA Position: Q1 2026 in Review

Jim Simons held its Sinovac Biotech, Ltd (SVA) position steady in Q1 2026 at 1,312,520 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3793.

Jim Simons first reported a position in SVA in Q2 2013 and has held it in 45 quarters since. The position peaked at $22.7M in Q1 2018. 28 funds tracked by Wall St. Rank hold SVA as of Q1 2026.

  • Jim Simons held 1,312,520 shares of Sinovac Biotech, Ltd worth $0 as of Q1 2026.
  • Jim Simons left its Sinovac Biotech, Ltd share count unchanged in Q1 2026.
  • Sinovac Biotech, Ltd made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3793 holding.
  • Jim Simons first reported a position in Sinovac Biotech, Ltd in Q2 2013 and has held it in 45 quarters since.
  • Jim Simons's Sinovac Biotech, Ltd position peaked at $22.7M in Q1 2018.
  • 28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.